In Silico Clinical Trials Global Market Report 2023-2033 - Growing Support and Recognition from Regulatory Bodies like the FDA and EMA is Significantly Boosting the Adoption of In Silico C...
Certara, Inc. (CERT)
Company Research
Source: Yahoo! Finance
The in silico clinical trials market was valued at US$3.07 billion in 2023 and is projected to grow at a CAGR of 8% during the forecast period 2023-2033. Strong revenue growth is predicted through to 2033. Better Understanding of the Safety Aspects of the Drug and Increasing Initiatives Projected to Boost Industry growth The in silico clinical trials market is experiencing remarkable growth, largely fueled by two key driving factors. Firstly, the efficiency in rapidly evaluating the safety and efficacy of medical products through virtual patient cohorts and simulations is a prominent catalyst for the growth of the market. By mimicking illness and treatment scenarios, these methods efficiently pinpoint safety concerns and provide valuable insights into product effectiveness. Pharmaceutical companies are drawn to this approach due to its ability to expedite the acquisition of crucial safety and efficacy data required for regulatory approvals. Secondly, the burgeoning support and
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform [Yahoo! Finance]Yahoo! Finance
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software PlatformGlobeNewswire
- Certara, Inc. (NASDAQ: CERT) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $23.00 price target on the stock.MarketBeat
- Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare ConferenceGlobeNewswire
- Certara, Inc. (NASDAQ: CERT) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.MarketBeat
CERT
Earnings
- 2/29/24 - In-Line
CERT
Sec Filings
- 4/12/24 - Form DEFA14A
- 4/10/24 - Form ARS
- 4/10/24 - Form DEFA14A
- CERT's page on the SEC website